PIK3CB and ovarian carcinoma: In addition, the pan-PI3K inhibitor wortmannin has been shown both to enhance apoptosis in platinum-resistant ovarian cancer cells (A2780cis)[84], and to sensitize ovarian cancer cells to cisplatin in Caov3 mouse models[85].